Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Peijia Medical Ltd. ( (HK:9996) ).
Peijia Medical Ltd. announced that its registration application for the GeminiOne® transcatheter edge-to-edge repair system has been accepted by the National Medical Products Administration of China. This novel device, featuring a unique sliding groove mechanism and other innovations, aims to simplify procedures and accommodate a wider range of anatomical variations, potentially enhancing the company’s market position in the medical device industry.
The most recent analyst rating on (HK:9996) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Peijia Medical Ltd. stock, see the HK:9996 Stock Forecast page.
More about Peijia Medical Ltd.
Peijia Medical Ltd. is a company incorporated in the Cayman Islands, operating in the medical device industry. The company focuses on developing innovative medical technologies, particularly in the field of transcatheter heart valve repair systems.
Average Trading Volume: 2,343,625
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.51B
See more insights into 9996 stock on TipRanks’ Stock Analysis page.